These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 35404469)

  • 21. Integrated skin sensitization assessment based on OECD methods (II): Hazard and potency by combining kinetic peptide reactivity and the "2 out of 3" Defined Approach.
    Natsch A; Gerberick GF
    ALTEX; 2022; 39(4):647-655. PubMed ID: 35404468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated skin sensitization assessment based on OECD methods (III): Adding human data to the assessment.
    Natsch A
    ALTEX; 2023; 40(4):571-583. PubMed ID: 37074977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstructed human epidermis-based testing strategy of skin sensitization potential and potency classification using epidermal sensitization assay and in silico data.
    Mizumachi H; Suzuki S; Sakuma M; Natsui M; Imai N; Miyazawa M
    J Appl Toxicol; 2024 Mar; 44(3):415-427. PubMed ID: 37846211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated decision strategies for skin sensitization hazard.
    Strickland J; Zang Q; Kleinstreuer N; Paris M; Lehmann DM; Choksi N; Matheson J; Jacobs A; Lowit A; Allen D; Casey W
    J Appl Toxicol; 2016 Sep; 36(9):1150-62. PubMed ID: 26851134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated skin sensitization assessment based on OECD methods (I): Deriving a point of departure for risk assessment.
    Natsch A; Gerberick GF
    ALTEX; 2022; 39(4):636-646. PubMed ID: 35404469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A triangular approach for the validation of new approach methods for skin sensitization.
    Natsch A; Landsiedel R; Kolle SN
    ALTEX; 2021; 38(4):669-677. PubMed ID: 34247252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database.
    Hoffmann S; Kleinstreuer N; Alépée N; Allen D; Api AM; Ashikaga T; Clouet E; Cluzel M; Desprez B; Gellatly N; Goebel C; Kern PS; Klaric M; Kühnl J; Lalko JF; Martinozzi-Teissier S; Mewes K; Miyazawa M; Parakhia R; van Vliet E; Zang Q; Petersohn D
    Crit Rev Toxicol; 2018 May; 48(5):344-358. PubMed ID: 29474128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-animal methods to predict skin sensitization (II): an assessment of defined approaches
    Kleinstreuer NC; Hoffmann S; Alépée N; Allen D; Ashikaga T; Casey W; Clouet E; Cluzel M; Desprez B; Gellatly N; Göbel C; Kern PS; Klaric M; Kühnl J; Martinozzi-Teissier S; Mewes K; Miyazawa M; Strickland J; van Vliet E; Zang Q; Petersohn D
    Crit Rev Toxicol; 2018 May; 48(5):359-374. PubMed ID: 29474122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide reactivity assays for skin sensitisation - scope and limitations.
    Roberts DW
    Crit Rev Toxicol; 2022 Jul; 52(6):420-430. PubMed ID: 36542542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of human predictive patch test (HPPT) data for the classification of skin sensitization hazard and potency.
    Herzler M; Abedini J; Allen DG; Germolec D; Gordon J; Ko HS; Matheson J; Reinke E; Strickland J; Thierse HJ; To K; Truax J; Vanselow JT; Kleinstreuer N
    Arch Toxicol; 2024 May; 98(5):1253-1269. PubMed ID: 38483583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The local lymph node assay: past, present and future.
    Kimber I; Dearman RJ; Basketter DA; Ryan CA; Gerberick GF
    Contact Dermatitis; 2002 Dec; 47(6):315-28. PubMed ID: 12581276
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.